Canal Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Canal Capital Management's EXAS Position: Q1 2022 in Review
Canal Capital Management sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 11,753 shares — an estimated $915K sold.
Canal Capital Management first reported a position in EXAS in Q3 2020 and held it in 6 quarters. The position peaked at $1.52M in Q2 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.
- Canal Capital Management reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
- Canal Capital Management sold 11,753 Exact Sciences shares in Q1 2022, an estimated $915K.
- Canal Capital Management first reported a position in Exact Sciences in Q3 2020 and held it in 6 quarters.
- Canal Capital Management's Exact Sciences position peaked at $1.52M in Q2 2021.
- 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.
Based on Canal Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.